HQY vs. IQV, RDDT, GIB, CPAY, KSPI, AER, GRAB, TRU, TOST, and Z
Should you be buying HealthEquity stock or one of its competitors? The main competitors of HealthEquity include IQVIA (IQV), Reddit (RDDT), CGI (GIB), Corpay (CPAY), Joint Stock Company Kaspi.kz (KSPI), AerCap (AER), Grab (GRAB), TransUnion (TRU), Toast (TOST), and Zillow Group (Z). These companies are all part of the "business services" industry.
HealthEquity vs.
IQVIA (NYSE:IQV) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, earnings and profitability.
IQVIA has a net margin of 8.91% compared to HealthEquity's net margin of 8.41%. IQVIA's return on equity of 28.81% beat HealthEquity's return on equity.
IQVIA currently has a consensus target price of $251.22, suggesting a potential upside of 29.49%. HealthEquity has a consensus target price of $110.71, suggesting a potential downside of 0.90%. Given IQVIA's higher probable upside, research analysts clearly believe IQVIA is more favorable than HealthEquity.
IQVIA has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500.
In the previous week, IQVIA had 22 more articles in the media than HealthEquity. MarketBeat recorded 33 mentions for IQVIA and 11 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.14 beat IQVIA's score of 0.96 indicating that HealthEquity is being referred to more favorably in the news media.
IQVIA received 147 more outperform votes than HealthEquity when rated by MarketBeat users. However, 70.04% of users gave HealthEquity an outperform vote while only 68.41% of users gave IQVIA an outperform vote.
89.6% of IQVIA shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 1.6% of IQVIA shares are owned by company insiders. Comparatively, 2.2% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
IQVIA has higher revenue and earnings than HealthEquity. IQVIA is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
Summary
IQVIA beats HealthEquity on 12 of the 19 factors compared between the two stocks.
Get HealthEquity News Delivered to You Automatically
Sign up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HealthEquity Competitors List
Related Companies and Tools
This page (NASDAQ:HQY) was last updated on 2/21/2025 by MarketBeat.com Staff
Free HQY Stock Alerts